Measuring event-related potentials.
Dixon
R
R
Zeneca Pharmaceuticals, Clinical Pharmacology Unit, Macclesfield, Cheshire, UK.
D000328:Adult; D001143:Arousal / Q000187:drug effects; D003265:Contingent Negative Variation; D020372:Dexfenfluramine / Q000494:pharmacology; D018913:Event-Related Potentials, P300; D016057:Evoked Potentials, Auditory, Brain Stem / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy / Q000503:physiopathology; D010080:Oxazoles / Q000494:pharmacology*; D023303:Oxazolidinones; D044302:Receptor, Serotonin, 5-HT1B; D044346:Receptor, Serotonin, 5-HT1D; D011985:Receptors, Serotonin / Q000187:drug effects; D017366:Serotonin Receptor Agonists / Q000494:pharmacology*; D014363:Tryptamines
C470302:HTR1B protein, human; D010080:Oxazoles; D023303:Oxazolidinones; D044302:Receptor, Serotonin, 5-HT1B; D044346:Receptor, Serotonin, 5-HT1D; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; C089750:zolmitriptan; D020372:Dexfenfluramine; C117402:183C91